Clinical Trial Update: Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 randomized placebo-controlled trial assessing safety, pharmacodynamics, and efficacy of ILV-094 in atopic dermatitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ILV-094 (ILV-094)

Snippet

Sponsor: Rockefeller University | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2019-05-07